OXON's International Programme for COVID-19
OXON is working with an international team of academics, and clinicians who treat COVID-19 patients, to help provide reliable evidence via non-randomised comparative studies of treatments for COVID-19 and prognostic factors to make decisions about pharmacological interventions in hospitalized COVID-19 patients.
Our activities include:
- Non-randomised comparative retrospective cohort analyses of treatments in hospitalised COVID-19 patients in Spain
- A ´real-time´ systematic review of non-randomised comparative studies of treatments for hospitalised patients with COVID-19 with requests for collaboration from study groups
- Meta-analysis of non-randomised comparative studies of treatments in hospitalised COVID-19 patients
- Seek to homogenise non-randomised comparative analyses of treatments in hospitalised COVID-19 patients where there are discrepant results between studies by collaboration with other study groups
- Comparison of non-randomised comparative studies of treatments in hospitalised COVID-19 patients and RCTs, cumulatively as these studies are published
Our projects are registered in the EUPAS register and PROSPERO register.
To follow information on these projects, please visit covid19@oxonepi.com